Literature DB >> 1371931

Characterization of apolipoprotein B mRNA editing from rabbit intestine.

Z C Garcia1, K S Poksay, K Boström, D F Johnson, M E Balestra, I Shechter, T L Innerarity.   

Abstract

Apolipoprotein (apo) B-48 is generated by a unique physiological process. Cytidine 6,666 of the apo B primary transcript is posttranscriptionally converted to a uridine by an RNA editing mechanism that transforms the codon for glutamine 2,153 to a termination codon. The editing reaction can be duplicated in a cell-free extract. In this study, the apo B-48 mRNA editing activity derived from partially purified extracts of rabbit enterocytes was characterized. The optimum conditions for the editing reaction were determined to be a salt concentration of 0.125-0.150 M NaCl or KCl, a pH of 8-8.5, and a temperature of 30 degrees C. The reaction rate was linear up to 45 minutes and was proportional to the editing extract concentration. No metal ion cofactors, DNA or RNA cofactors, or energy requirements were identified. At optimum conditions, the reaction followed Michaelis-Menten kinetics, with a Km of 0.4 nM for the rabbit RNA substrate. In addition, the reaction rate was enhanced by the addition of 25 micrograms/ml heparin or 40% glycerol. The characteristics of the editing reaction suggest that it is catalyzed by a nucleotide sequence-specific cytidine deaminase that is either a single enzyme or a multimeric protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371931     DOI: 10.1161/01.atv.12.2.172

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  8 in total

1.  Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.

Authors:  David Meriwether; Dawoud Sulaiman; Alan Wagner; Victor Grijalva; Izumi Kaji; Kevin J Williams; Liqing Yu; Spencer Fogelman; Carmen Volpe; Steven J Bensinger; G M Anantharamaiah; Ishaiahu Shechter; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Lipid Res       Date:  2016-05-19       Impact factor: 5.922

2.  Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.

Authors:  G S Dance; P Beemiller; Y Yang; D V Mater; I S Mian; H C Smith
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

3.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.

Authors:  G S Dance; M P Sowden; Y Yang; H C Smith
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

5.  Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site.

Authors:  N Navaratnam; R Shah; D Patel; V Fay; J Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

6.  Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA.

Authors:  D M Driscoll; S Lakhe-Reddy; L M Oleksa; D Martinez
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.

Authors:  A Mehta; D M Driscoll
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  Multiple functions of microsomal triglyceride transfer protein.

Authors:  M Mahmood Hussain; Paul Rava; Meghan Walsh; Muhammad Rana; Jahangir Iqbal
Journal:  Nutr Metab (Lond)       Date:  2012-02-21       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.